Product Description

CTX GLS 1gm Injection is a chemotherapy drug containing the active constituent cyclophosphamide. It is used to treat various malignancies (abnormal production of cells is called cancer; if they spread, those are called malignancies). CTX GLS 1gm Injection can be used to treat malignant lymphomas (cancers that start from the lymphatic system of the body- vessels, fluid, and lymphoid tissue) such as Hodgkin’s disease, lymphocytic lymphoma, and mixed-cell type lymphoma. 

It is used to treat leukemias, neuroblastoma, ovarian cancer, retinoblastoma, and breast carcinoma. It can also be used to treat Minimal Change Nephrotic syndrome in pediatric patients (kidney disease in which large quantities of protein are lost in urine). CTX GLS 1gm Injection is contraindicated in pregnancy, patients with acute infections, urinary tract infections, urinary outflow obstruction, and bone marrow disorders. 

Treatment with CTX GLS 1gm Injection may lead to immune suppression, bone marrow failure, cardiotoxicity, renal toxicity, pulmonary toxicity, and secondary malignancies. Inform your doctor if you have pre-existing kidney disease, immune conditions, cardiac disorders, or liver diseases.

How to use

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Uses

Treatment of Cancer
Treatment of Nephrotic syndrome

Side Effects

Serious:

• Infections
• Immune suppression
• Blood disorders
• Allergic reactions
• Abnormal liver function
• Inflammation of the bladder
• Kidney diseases
• Blood in urine
• Sterility
• Impaired wound healing

Common:

• Nausea, vomiting
• Low white blood cell count
• Diarrhea
• Hair loss
• Fever
• Weakness
• Inflammation
• Dizziness
• Blurred vision
• Amenorrhea

Storage

Do not freeze,Store in a refrigerator 2 - 8℃